Related Experiment Video
Updated: Jun 26, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Frontotemporal dementia neuroimaging: a guide for clinicians
Frontiers of Neurology and Neuroscience
|February 3, 2009
Summary
Frontotemporal dementia (FTD) and Alzheimer's disease (AD) require accurate diagnosis. Advanced neuroimaging biomarkers are crucial for differentiating these dementias and monitoring future molecular therapies.
Area of Science:
- Neurology
- Neuroimaging
- Biomarkers
Background:
- Frontotemporal dementia (FTD) is a significant cause of dementia.
- Accurate differentiation between FTD and Alzheimer's disease (AD) is clinically essential.
- Emerging molecular therapies necessitate improved diagnostic tools.
Purpose of the Study:
- To highlight the role of neuroimaging in distinguishing FTD from AD.
- To discuss the need for advanced biomarkers for diagnosis and treatment monitoring.
- To outline future directions in neuroimaging research for dementia.
Main Methods:
- Review of current neuroimaging techniques, particularly structural MRI.
- Discussion of the diagnostic utility of neuroimaging in differentiating dementia subtypes.
- Exploration of future research avenues in neuroimaging.
Main Results:
- Structural MRI is a valuable tool for differentiating FTD from AD and non-neurodegenerative conditions.
- Current imaging methods aid in clinical assessment and differential diagnosis.
- Future research aims to directly assess pathophysiology and protein accumulation.
Conclusions:
- Neuroimaging biomarkers are vital for accurate FTD and AD diagnosis.
- Advanced imaging techniques will enable better treatment monitoring.
- Future research will focus on network pathophysiology and protein-based imaging.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...